Drug intelligence / Profile preview

bu qi yi jing sheng xue

Development stage: Unknown
Lead developer: Affiliated Traditional Chinese Medicine Hospital of Guangzhou Medical University
Administration: Oral

Overview

Bu qi yi jing sheng xue is a Traditional Chinese Medicine (TCM) herbal therapy developed by the Guangzhou Hospital of Traditional Chinese Medicine. The name translates to "Tonifying Qi, Benefiting Essence, and Generating Blood," reflecting its therapeutic intent in TCM theory. It is primarily investigated for the treatment of children with beta-thalassemia, where it is hypothesized to improve clinical symptoms and potentially modulate molecular pathways related to hemoglobin production or erythropoiesis. The therapy is typically administered as an oral decoction or granule formulation.

Other names: Bu-qi-yi-jing-sheng-xue therapyBuqi Yijing Shengxue

Targets

HBG2 (Hemoglobin subunit gamma-2)

Beyond the preview

Go deeper on bu qi yi jing sheng xue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bu qi yi jing sheng xue.

Explore the full profile